A NIDA funded analysis of data from the 2018 National Survey of Substance Abuse Treatment Services assessed availability of HIV testing and counseling services in U.S. substance use treatment facilities. Among these facilities, investigators found only three in ten offered HIV testing. Additionally, HIV testing was more likely to be offered in facilities that offered medication for opioid use disorder. Overall, in only three states was HIV testing offered by at least 50% of facilities. These findings “suggest a missed opportunity for early identification of HIV among people receiving treatment for substance use disorders.” Click here to read the article in its entirety.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.